GlassScriptPhysician profile
Dominique J Smith
NPI 1700871241
$981.32
in general payments reported to CMS, 2019-2025
14 companies · $318 in 2025
The $318 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $59.93 · 2020: $52.17 · 2021: $54.83 · 2022: $193 · 2023: $192 · 2024: $111 · 2025: $318.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $521 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $520.95 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $246.71 | 2022-2023 | |
| Astellas Pharma US INC | $153.49 | 2023-2025 | Veozah |
| Abbott Laboratories | $138.09 | 2025 | Thoratec Heartmate 3 Lvas Implant Kit |
| Abbvie INC. | $96.23 | 2020-2025 | |
| Therapeuticsmd, INC. | $76.49 | 2019-2021 | |
| Sumitomo Pharma America, INC. | $66.31 | 2024-2025 | Myfembree |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $51.12 | 2023 | Xifaxan, Trulance |
| Radius Health, INC. | $33.73 | 2021-2022 | |
| Dexcom, INC. | $23.97 | 2024 | Dexcom G6 Transmitter |
| Medtronic, INC. | $23.33 | 2023 | Interstim |
| Bayer Healthcare Pharmaceuticals INC. | $23.30 | 2019 | |
| Glaxosmithkline, LLC. | $18.25 | 2025 | Benlysta |
| Lilly USA, LLC | $16.40 | 2024 | Jardiance, Zepbound |
| Pfizer INC. | $13.90 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dominique Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.